Literature DB >> 8134208

Neurologic manifestations of cocaine exposure in childhood.

S H Mott1, R J Packer, S J Soldin.   

Abstract

OBJECTIVE: To describe the neurologic manifestations of cocaine exposure in children and adolescents as the neurologic effects of cocaine have been described in adults and neonates.
METHODS: During 1-year period, 41 children between the ages of 2 months and 18 years who had been exposed to cocaine, were examined in the emergency department at the Children's National Medical Center. Cocaine exposure was documented on urine samples; all were confirmed by urine gas chromatographic/mass spectrometric analysis.
RESULTS: Nineteen (46%) of 41 had neurologic abnormalities, including seizures (7), obtundation (6), delirium (4), dizziness (1), drooling (1), and ataxia (1). In 14 others, the neurologic effects of cocaine were difficult to determine because of other concomitant medical conditions, including head injuries and severe abdominal or chest trauma. Two major age-related patterns were seen: (a) in each child < 5 years of age, seizures and obtundation; and (b) in 11 older children, delirium (3), dizziness (1), drooling (2), and lethargy (4). Seizures, occurring at ages 12 months to 8 years, were focal with secondary generalization in three and generalized in four. They were associated with fever in two children. Six children had no further seizures, and one developed a mixed-seizure disorder. Passive intoxication while being in a room in which "crack" was smoked was the most likely cause of exposure for young victims. Multiple drug abuse was not documented in any child with neurologic impairment.
CONCLUSIONS: 1) Cocaine exposure is common in children in our urban setting; 2) neurologic manifestations frequently occur; 3) in children 8 years of age or younger, "passive" ingestion/inhalation is associated with focal and generalized seizures without evidence of structural brain injury; 4) cocaine may lower seizure threshold in children predisposed to seizures; 5) in children > 8 years of age, manifestations are similar to those in adults; 6) trauma and motor vehicle accidents were seen in the adolescent age group exposed to cocaine; and 7) urine toxicological study in cocaine exposure is recommended in all first-time seizures as well as first-time febrile seizures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134208

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  The importance of neurobiological research to the prevention of psychopathology.

Authors:  D Fishbein
Journal:  Prev Sci       Date:  2000-06

Review 2.  Delirium: an important (but often unrecognized) clinical syndrome.

Authors:  Terry Rabinowitz
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

4.  Drooling in children.

Authors:  A K Leung; C P Kao
Journal:  Paediatr Child Health       Date:  1999-09       Impact factor: 2.253

5.  Passive environmental exposure to cocaine in Canadian children.

Authors:  Facundo Garcia-Bournissen; Maria Nesterenko; Tatyana Karaskov; Gideon Koren
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Assessment of unsuspected exposure to drugs of abuse in children from a Mediterranean city by hair testing.

Authors:  Simona Pichini; Oscar Garcia-Algar; Airam Alvarez; Massimo Gottardi; Emilia Marchei; Fiorenza Svaizer; Manuela Pellegrini; Maria Concetta Rotolo; Roberta Pacifici
Journal:  Int J Environ Res Public Health       Date:  2014-02-21       Impact factor: 3.390

7.  Pediatric exposure to drugs of abuse by hair testing: monitoring 15 years of evolution in Spain.

Authors:  Simona Pichini; Oscar García-Algar; Airam-Tenesor Alvarez; Maria Mercadal; Claudia Mortali; Massimo Gottardi; Fiorenza Svaizer; Roberta Pacifici
Journal:  Int J Environ Res Public Health       Date:  2014-08-14       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.